Abstract:Andy Petroianu Department of Surgery, School of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil Comment on: Nesti C, Bräutigam K, Benavent M, et al . Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study. Lancet Oncol 2023;24:187-94. Keywords: Appendix; neuroendocrine tumour (NET); appendectomy Submitted Mar 23, 2023. Accepted for publication Jul 16, 2024. Published online Aug 23, 2024. doi: 10.21037/tcr-23-510 This outstanding and up-to-date work studied 278 appendiceal neuroendocrine tumours (NETs) of one to two centimetres in size, which were completely resected by means of appendectomy or right-sided hemicolectomy. This retrospective cohort study, assessed patients from 40 hospitals in 15 European countries, considering any age and sex, with more than 10 years of follow-up after the surgical procedure (1). The appendix is a relatively unknown organ, considering the enigmatic role it plays in the body (2). In spite of the large number of published studies about the appendix, its disorders are still incomprehensible. To reinforce this concept, diseases associated with right-side abdominal pain, having been described for many centuries, are still difficult to identify (3). All theories concerning the appendix are controversial and no symptom or sign may be ascribed to any appendicopathy as pathognomonic. Therefore, the diagnosis of appendiceal disorders continues to be a medical challenge (3,4). Acute appendicitis, which is the most frequent appendiceal disease, is prevalent in white skin patients (74%) with an incidence of 23 per 10,000 people per year (2,5). Radiographic signs suggestive of appendicitis include appendiceal faecalith, gas in the appendix, air-fluid levels or distension of the terminal ileum, caecum, and ascending colon, which are signs of localised paralytic ileum (6). These radiological signs have a sensitivity of 97% and a specificity of 85% (7,8). The appendiceal characteristics are different from all other digestive organs and do not seem to be linked to digestion. The high amount of neuroendocrine and immune cells in the appendix wall, as well as its disorders, are related to neuroendocrine and immune systems, but not necessarily to inflammation (9,10). More than 20% of all patients with clinical manifestations of appendicitis do not present appendiceal inflammation, but rather a different appendicopathy (11,12). Since the early twentieth century, several studies have ascribed this disease to disorders of neuroendocrine and immune mediators located in the appendix, which occur at a similar age and sex of acute appendicitis. However, the etiology, activating factors, and pathophysiology of this appendicopathy are still unknown (11-14). Apparently normal appendices removed from patients with clinical manifestations of acute appendicitis have revealed a greater expression in substance P neuroendocrine markers, vasoactive intestinal polypeptide, gastric inhibitory polypeptide, calcium-binding protein, cyclooxygenases 1 and 2, tumour necrosis factor, prostaglandin E2, mast cell tryptase, nitric oxide synthase, CD8 lymphocytes, protein gene product 9.5, vascular endothelial growth factor, class 2 histocompatibility complex, synaptophysin, enolase, and S100 protein (15-17). At least some of these mediators are responsible for fever, nausea, vomiting, abdominal pain and diarrhoea. Thus, apparently normal appendices removed from patients with a clinical look of acute appendicitis present neuroendocrine disorders (2,5,11,12). Patients over 40 years old presenting with appendicitis manifestations and an appendiceal diameter >10 mm seems to have a greater risk of malignancy (3). The presence of an appendiceal malignancy should be considered in the management of older patients with acute appendicitis before indicating non-operative therapy (17). The most frequent cancer of the digestive system is adenocarcinoma, including the goblet cell tumour, which sometimes shows carcinoid-like expansion and may confound the diagnosis. The characteristic appendiceal malignancy is the NET, mainly the carcinoid tumour (18,19). Somatostatinoma and paraganglioma are other rare NETs that may originate in appendices (19,20). More than 80% of all NETs are incidentally found in appendices removed due to a diagnosis of acute appendicitis (18-20). They usually progress indolently and are diagnosed one decade later than acute appendicitis. In fact, the clinical manifestation of acute appendicitis and NET are similar, except for the symptoms due to serotonin secretion of carcinoid tumours, mainly flushing, diarrhoea, and bronchospasm. These clinical manifestations of carcinoid syndrome are mainly found when the NETs are associated with liver metastases (19,21). Their epidemiologic findings of age and sex are also di -Abstract Truncated-

Appendiceal Neuroendocrine Neoplasms: an Update for 2023

Characteristics and Management of Children with Appendiceal Neuroendocrine Neoplasms: A Single-Center Study

Immunohistochemistry features and molecular pathology of appendiceal neoplasms

[Prognostic Analysis and Clinicopathological Features of 20 Patients with Appendiceal Neuroendocrine Neoplasms].

Appendiceal Well-Differentiated Neuroendocrine Tumors: A Single-Center Experience and New Insights into the Effective Use of Immunohistochemistry

Survival Profile and Prognostic Factors for Appendiceal Mixed Neuroendocrine Non-neuroendocrine Neoplasms: A SEER Population-Based Study

The Promise of Epigenetics Research in the Treatment of Appendiceal Neoplasms

Beyond acute appendicitis: a single-institution experience of unexpected pathology findings after 989 consecutive emergency appendectomy

Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1-2 cm in size: a retrospective, Europe-wide, pooled cohort study

Clinicopathologic features and diagnostic challenges of small cluster pattern appendiceal neuroendocrine tumors

Clinical Intricacies and Advances in Neuroendocrine Tumors: An Organ-Based Multidisciplinary Approach

Current Status of Treatment among Patients with Appendiceal Tumors—Old Challenges and New Solutions?

Treatment of appendiceal neuroendocrine tumour: a controversial treatment for a misunderstood neoplasm in a mysterious organ

Clinical and pathologic characteristics of appendiceal neuroendocrine neoplasms diagnosed during pregnancy

Appendiceal Neoplasm: It's Never What It Seems

Neuroendocrine appendiceal tumor and endometriosis of the appendix: a case report

An Update on the Management of Rectal Neuroendocrine Neoplasms

Appendiceal mucinous neoplasm in adolescence: Diagnosis, management, and surveillance

Diagnostic challenges and prognostic implications of extranodal extension in head and neck cancer: a state of the art review and gap analysis

Nonneoplastic pathology of the appendix: A review article, based on the recent literature

The Clinicopathological Significance of Tumor Cell Subtyping in Appendiceal Neuroendocrine Tumors: A Series of 135 Tumors